Good news: EU nations have resumed Oxford vaccine. Bad news: They don’t have enough doses

The investigations into the risk of blood clots are not the only issues the AstraZeneca vaccine is facing.

Megan Clement, The Conversation

· Mar 19, 2021 · 11:30 pm